How cancer immunotherapies affect the heart

Checkpoint inhibitors help fight cancer but increase the risk of heart disease. An interdisciplinary team, including researchers from the Max Delbrück Center, is investigating how the therapy can be made safer. The Hector Foundation is supporting the…

3 Min
More

German Start-Up Remi Health raises €5m to scale Diagnostics-as-a-Service platform across Europe

Remi Health, the Diagnostics-as-a-Service platform, today announced it has secured an oversubscribed €3 million seed round, bringing total funding to €5 million. The round was led by IBB Ventures, with participation from Catalpa Ventures, MSD Global…

4 Min
More

Berlin University Alliance Secures Continued Funding in Excellence Strategy – A First for a University Consortium

As Germany’s first University Consortium of Excellence, the Berlin University Alliance (BUA) is maintaining its outstanding position in the German research landscape under the federal and state governments’ Excellence Strategy. The Excellence…

5 Min
More

Alexandra Knauer receives the Pittcon Heritage Award

Entrepreneur Alexandra Knauer, managing director of lab instrument manufacturer KNAUER, is honored in the USA with the Pittcon Heritage Award 2026.

2 Min
More

Japan | Personalized and regenerative medicine | Delegationsreise

October 05.–09. 2026 | Registration open

1 Min
More

Mastering the jungle of guidelines with AI

Public-private consortium developing therapy assistants for doctors in Europe

5 Min
More
[Translate to English:]

Interview | Aleksandar Ivanovski | “Whether AI will change healthcare is no longer up for debate.”

Aleksandar Ivanovski is a senior machine learning engineer at Recare, a Berlin-based company that has been developing digital discharge management for hospitals since 2017 and now connects more than 700 acute care clinics.

1 Min
More

Equality in research drives innovation

Marking International Women's Day, Federal Research Minister Dorothee Bär met with female researchers at the Max Delbrück Center in Berlin-Mitte to discuss advancing equality in science.

2 Min
More

T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors

Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation

3 Min
More

Research Fellowship in Public Health Intelligence

Application deadline: 3 March 2026

1 Min
More
Show more items